Background: Several vaccine platforms have been successfully evaluated for prevention of Ebola virus (EBOV) disease (EVD) in nonhuman primates and humans. Despite remarkable efficacy by multiple vaccines, the immunological correlates of protection against EVD are incompletely understood. Methods: We systematically evaluated the antibody response to various EBOV proteins in 79 nonhuman primates vaccinated with various EBOV vaccine platforms. We evaluated the serum immunoglobulin (Ig)G titers against EBOV glycoprotein (GP), the ability of the vaccine-induced antibodies to bind GP at acidic pH or to displace ZMapp, and virus neutralization titers. The correlation of these outcomes with survival from EVD was evaluated by appropriate statistical methods. Results: Irrespective of the vaccine platform, protection from EVD strongly correlated with anti-GP IgG titers. The GP-directed antibody levels required for protection in animals vaccinated with virus-like particles (VLPs) lacking nucleoprotein (NP) was significantly higher than animals immunized with NP-containing VLPs or adenovirus-expressed GP, platforms that induce strong T-cell responses. Furthermore, protective immune responses correlated with anti-GP antibody binding strength at acidic pH, neutralization of GP-expressing pseudovirions, and the ability to displace ZMapp components from GP. Conclusions: These findings suggest key quantitative and qualitative attributes of antibody response to EVD vaccines as potential correlates of protection.
Background: Several vaccine platforms have been successfully evaluated for prevention of Ebola virus (EBOV) disease (EVD) in nonhuman primates and humans. Despite remarkable efficacy by multiple vaccines, the immunological correlates of protection against EVD are incompletely understood. Methods: We systematically evaluated the antibody response to various EBOV proteins in 79 nonhuman primates vaccinated with various EBOV vaccine platforms. We evaluated the serum immunoglobulin (Ig)G titers against EBOV glycoprotein (GP), the ability of the vaccine-induced antibodies to bind GP at acidic pH or to displace ZMapp, and virus neutralization titers. The correlation of these outcomes with survival from EVD was evaluated by appropriate statistical methods. Results: Irrespective of the vaccine platform, protection from EVD strongly correlated with anti-GP IgG titers. The GP-directed antibody levels required for protection in animals vaccinated with virus-like particles (VLPs) lacking nucleoprotein (NP) was significantly higher than animals immunized with NP-containing VLPs or adenovirus-expressed GP, platforms that induce strong T-cell responses. Furthermore, protective immune responses correlated with anti-GP antibody binding strength at acidic pH, neutralization of GP-expressing pseudovirions, and the ability to displace ZMapp components from GP. Conclusions: These findings suggest key quantitative and qualitative attributes of antibody response to EVD vaccines as potential correlates of protection.
Authors: Xuelian Zhao; Katie A Howell; Shihua He; Jennifer M Brannan; Anna Z Wec; Edgar Davidson; Hannah L Turner; Chi-I Chiang; Lin Lei; J Maximilian Fels; Hong Vu; Sergey Shulenin; Ashley N Turonis; Ana I Kuehne; Guodong Liu; Mi Ta; Yimeng Wang; Christopher Sundling; Yongli Xiao; Jennifer S Spence; Benjamin J Doranz; Frederick W Holtsberg; Andrew B Ward; Kartik Chandran; John M Dye; Xiangguo Qiu; Yuxing Li; M Javad Aman Journal: Cell Date: 2017-05-18 Impact factor: 41.582
Authors: Surender Khurana; Sandra Fuentes; Elizabeth M Coyle; Supriya Ravichandran; Richard T Davey; John H Beigel Journal: Nat Med Date: 2016-10-31 Impact factor: 53.440
Authors: James Pettitt; Larry Zeitlin; Do H Kim; Cara Working; Joshua C Johnson; Ognian Bohorov; Barry Bratcher; Ernie Hiatt; Steven D Hume; Ashley K Johnson; Josh Morton; Michael H Pauly; Kevin J Whaley; Michael F Ingram; Ashley Zovanyi; Megan Heinrich; Ashley Piper; Justine Zelko; Gene G Olinger Journal: Sci Transl Med Date: 2013-08-21 Impact factor: 17.956
Authors: Kelly L Warfield; Dana L Swenson; Gene G Olinger; Warren V Kalina; M Javad Aman; Sina Bavari Journal: J Infect Dis Date: 2007-11-15 Impact factor: 5.226
Authors: Thomas W Geisbert; Kathleen M Daddario-Dicaprio; Joan B Geisbert; Douglas S Reed; Friederike Feldmann; Allen Grolla; Ute Ströher; Elizabeth A Fritz; Lisa E Hensley; Steven M Jones; Heinz Feldmann Journal: Vaccine Date: 2008-10-18 Impact factor: 3.641
Authors: Kelly L Warfield; John M Dye; Jay B Wells; Robert C Unfer; Frederick W Holtsberg; Sergey Shulenin; Hong Vu; Dana L Swenson; Sina Bavari; M Javad Aman Journal: PLoS One Date: 2015-03-20 Impact factor: 3.240
Authors: Xiangguo Qiu; Gary Wong; Jonathan Audet; Alexander Bello; Lisa Fernando; Judie B Alimonti; Hugues Fausther-Bovendo; Haiyan Wei; Jenna Aviles; Ernie Hiatt; Ashley Johnson; Josh Morton; Kelsi Swope; Ognian Bohorov; Natasha Bohorova; Charles Goodman; Do Kim; Michael H Pauly; Jesus Velasco; James Pettitt; Gene G Olinger; Kevin Whaley; Bianli Xu; James E Strong; Larry Zeitlin; Gary P Kobinger Journal: Nature Date: 2014-08-29 Impact factor: 49.962
Authors: Axel T Lehrer; Teri-Ann S Wong; Michael M Lieberman; Lisa Johns; Liana Medina; Friederike Feldmann; Heinz Feldmann; Andrea Marzi Journal: Vaccine Date: 2019-07-16 Impact factor: 3.641
Authors: Roberto Biselli; Roberto Nisini; Florigio Lista; Alberto Autore; Marco Lastilla; Giuseppe De Lorenzo; Mario Stefano Peragallo; Tommaso Stroffolini; Raffaele D'Amelio Journal: Biomedicines Date: 2022-08-22
Authors: Eleonora Vianello; Patricia Gonzalez-Dias; Suzanne van Veen; Carmen G Engele; Edwin Quinten; Thomas P Monath; Donata Medaglini; Francesco Santoro; Angela Huttner; Sheri Dubey; Michael Eichberg; Francis M Ndungu; Peter G Kremsner; Paulin N Essone; Selidji Todagbe Agnandji; Claire-Anne Siegrist; Helder I Nakaya; Tom H M Ottenhoff; Mariëlle C Haks Journal: Lancet Microbe Date: 2021-12-06
Authors: Yimeng Wang; Katie A Howell; Jennifer Brannan; Krystle N Agans; Hannah L Turner; Ariel S Wirchnianski; Shweta Kailasan; Marnie Fusco; Andrey Galkin; Chi-I Chiang; Xuelian Zhao; Erica Ollmann Saphire; Kartik Chandran; Andrew B Ward; John M Dye; M Javad Aman; Thomas W Geisbert; Yuxing Li Journal: J Virol Date: 2021-02-03 Impact factor: 6.549
Authors: Jennifer M Brannan; Shihua He; Katie A Howell; Laura I Prugar; Wenjun Zhu; Hong Vu; Sergey Shulenin; Shweta Kailasan; Henna Raina; Gary Wong; Md Niaz Rahim; Logan Banadyga; Kevin Tierney; Xuelian Zhao; Yuxing Li; Frederick W Holtsberg; John M Dye; Xiangguo Qiu; M Javad Aman Journal: Nat Commun Date: 2019-01-10 Impact factor: 14.919
Authors: Michelle Meyer; Bronwyn M Gunn; Delphine C Malherbe; Karthik Gangavarapu; Asuka Yoshida; Colette Pietzsch; Natalia A Kuzmina; Erica Ollmann Saphire; Peter L Collins; James E Crowe; James J Zhu; Marc A Suchard; Douglas L Brining; Chad E Mire; Robert W Cross; Joan B Geisbert; Siba K Samal; Kristian G Andersen; Galit Alter; Thomas W Geisbert; Alexander Bukreyev Journal: Sci Transl Med Date: 2021-07-14 Impact factor: 17.956
Authors: Kimberley Steeds; Yper Hall; Gillian S Slack; Stephanie Longet; Thomas Strecker; Sarah Katharina Fehling; Edward Wright; Joseph Akoi Bore; Fara Raymond Koundouno; Mandy Kader Konde; Roger Hewson; Julian A Hiscox; Georgios Pollakis; Miles W Carroll Journal: Sci Rep Date: 2020-08-31 Impact factor: 4.996